Reduce radiation by at least 50%. Compromise nothing.

ControlRad is a privately held medical technology company developing innovative products that dramatically reduce the potentially life-altering radiation exposure from fluoroscopically guided procedures for patients and healthcare professionals.

ControlRad is your answer to the guiding principle of radiation safety - ALARA. Using our dynamic, intelligent collimation technology, ControlRad reduces harmful, unnecessary radiation exposure to the patient and medical personnel by at least 50%. Maintain image quality where it matters, while reducing unnecessary radiation in the periphery. With no capital expense, ControlRad is integrated onto facilities' existing mobile C-arms, so wherever your C-arm goes, so does the benefit.

ControlRad is headquartered in Atlanta, Georgia and has engineering development facilities in Kfar Saba, Israel. For more information, visit www.controlrad.com.

Brands: ControlRad Trace for Mobile C-arms


 Videos

ControlRad Trace Animation

 Chat or Meet with a Representative

  • (Oct 02, 2020)

 Press Releases

  • ATLANTA, September 15, 2020 – ControlRad, Inc., a privately held medical technology company focused on dramatically reducing unnecessary radiation exposure during fluoroscopically guided procedures, today announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for ControlRad Trace use on OEC 9900 Mobile C-arms.  “This additional FDA clearance allows us to offer the critically-important protection of our radiation reduction technology to even more patients and staff in need of mobile C-arm related procedures,” stated Chris Fair, EVP & President of ControlRad.  

    In addition to the regulatory clearance, ControlRad announced today that they have closed a Series C financing round led by current investor Questa Capital.  “We are extremely appreciative for the additional investment from Questa and also pleased to welcome new investor Windham Ventures to our investor group. We are excited to further build our commercial reach to advance our efforts to help save patients and clinical staff from the harmful effects of excessive radiation,” stated Guillaume Bailliard, CEO of ControlRad.

    “We believe that ControlRad’s Trace technology is vital to reducing radiation exposure in the clinical setting, and we are proud to be investors in a breakthrough technology with a great management team focused on commercial execution,” stated Ryan Drant, Founder and Managing Partner, Questa Capital.  

    With its proprietary semi-transparent filter, tablet and image processing technology, the ControlRad Trace solution can be retrofitted onto existing mobile C-arms, reducing the barrier to adopting the technology in order to reduce unnecessary radiation without compromising image quality in the region of interest or overall workflow.

    email info@ControlRad.com.  
     

    About ControlRad  
     

    ControlRad is a privately held medical technology company developing innovative products that dramatically reduce the radiation exposure from fluoroscopically guided procedures (FGP) for patients and healthcare professionals. ControlRad’s products are designed to improve safety without compromising image quality or workflow. They include an integrated set of proprietary components, which optimize the X-ray beam to deliver optimal image quality in the clinically relevant region while maintaining appropriate resolution in the periphery. ControlRad is headquartered in Atlanta, Georgia, and has engineering development facilities in Kfar Saba, Israel. For more information, visit www.controlrad.com.


 Featured Products

  • ControlRad Trace for Mobile C-arms
    ControlRad Trace reduces harmful, unnecessary radiation exposure to the patient and medical personnel by at least 50%. ControlRad doesn't compromise image quality nor negatively impact workflow....


  • ControlRad Trace features include:

    • Dynamic Filter System

    • Intelligent Collimation

    • Tablet Interface

    • Proprietary Image Processing Algorithm

    • Retrofits on Existing Mobile C-arms (GE OEC 9800/9800 Plus and 9900 Elite models)

    • No Capital Expenses


    How ControlRad Trace Works:

    1. Draw the ROI

    Define the desired Region of Interest (ROI) by drawing on the ControlRad Tablet’s intuitive touch screen.

    2. Filters Adjust

    The system’s semi-transparent titanium plates then move in direct response to the tablet interface to create the precise ROI window.

    The intelligent filters deliver the useful amount of radiation within the ROI, while eliminating a majority of the unnecessary scatter radiation elsewhere.

    The image is processed through ControlRad Trace’s advanced algorithm to deliver a high-quality image of the ROI, while maintaining adequate resolution in the periphery 

    3. Reduce Radiation

    The result is a reduction in Dose Area Product (DAP) radiation by at least 50% without negatively impacting workflow or image quality within the ROI.

    This reduction rate is then displayed on the tablet and C-arm monitor in real-time.

    For more information on ControlRad Trace, click here.


Send Email

Type your information and click "Send Email" to send an email to this exhibitor. To return to the previous screen without saving, click "Reset".